The systemic intraperitoneal (i.p.) administration of the adenosine A2A agonist CGS 21680 was found to dose-dependently antagonize spontaneous and amphetamine-induced (1 mg/kg i.p.) motor activity with similar ED50 values (about 0.2 mg/kg). The ratios between the ED50 values for induction of catalepsy and for antagonizing amphetamine-induced motor activity for CGS 21680, haloperidol, and clozapine were 12,2, and > 30, respectively. Furthermore, CGS 23680 was comparably much stronger than haloperidol or clozapine at antagonizing the motor activity induced by phencyclidine (2 mg/kg subcutaneonsly) than motor activity induced by amphetamine (1 mg/kg i.p.). In conclusion, the present results show a clear "atypical" antipsychotic profile of the adenosine A2A agonist CGS 21680 in animal models. © 1997 American College of Neuropsychopharmacohgy. Published by Elsevier Science Inc.

Adenosine A2A agonists: A potential new type of atypical antipsychotic / Rimondini R.; Ferre S.; Ogren S.O.; Fuxe K.. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - STAMPA. - 17:2(1997), pp. 82-91. [10.1016/S0893-133X(97)00033-X]

Adenosine A2A agonists: A potential new type of atypical antipsychotic

Rimondini R.
Primo
Investigation
;
1997

Abstract

The systemic intraperitoneal (i.p.) administration of the adenosine A2A agonist CGS 21680 was found to dose-dependently antagonize spontaneous and amphetamine-induced (1 mg/kg i.p.) motor activity with similar ED50 values (about 0.2 mg/kg). The ratios between the ED50 values for induction of catalepsy and for antagonizing amphetamine-induced motor activity for CGS 21680, haloperidol, and clozapine were 12,2, and > 30, respectively. Furthermore, CGS 23680 was comparably much stronger than haloperidol or clozapine at antagonizing the motor activity induced by phencyclidine (2 mg/kg subcutaneonsly) than motor activity induced by amphetamine (1 mg/kg i.p.). In conclusion, the present results show a clear "atypical" antipsychotic profile of the adenosine A2A agonist CGS 21680 in animal models. © 1997 American College of Neuropsychopharmacohgy. Published by Elsevier Science Inc.
1997
Adenosine A2A agonists: A potential new type of atypical antipsychotic / Rimondini R.; Ferre S.; Ogren S.O.; Fuxe K.. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - STAMPA. - 17:2(1997), pp. 82-91. [10.1016/S0893-133X(97)00033-X]
Rimondini R.; Ferre S.; Ogren S.O.; Fuxe K.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/826943
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 145
  • ???jsp.display-item.citation.isi??? 138
social impact